Compound Biejia-Ruangan tablet as an adjunctive therapy to entecavir for chronic hepatitis B complicated with hepatic fibrosis: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: The compound Biejia-Ruangan tablet (CBRT), as an adjunctive therapy to entecavir, is a potential treatment for hepatic fibrosis (HF) in patients with chronic hepatitis B (HBV). However, the present study yielded inconsistent results. In this systematic review and meta-analysis, we compre...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yong-hong, Xue, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371490/
https://www.ncbi.nlm.nih.gov/pubmed/35960113
http://dx.doi.org/10.1097/MD.0000000000030020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371490/
https://www.ncbi.nlm.nih.gov/pubmed/35960113
http://dx.doi.org/10.1097/MD.0000000000030020

Ejemplares similares